FDA Inspection 1223141 — Bloodworks
The FDA completed an inspection of Bloodworks on October 26, 2023 in Renton, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 26, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Renton, WA (United States)